Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma

References

• Carr T, Teucher U, Mann J, et al. Waiting for surgery from the patient perspective. Psychol Res Behav Manag. 2009;2:107–119.
   PubMedGoogle Scholar
• Lee CT, Madii R, Daignault S, et al. Cystectomy delay more Than 3 months From initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol. 2006;175(4):1262–1267.
   PubMed Web of Science ®Google Scholar
• Gore JL, Lai J, Setodji CM, the Urologic Diseases in America Project, et al. Mortality increases when radical cystectomy is delayed more than 12 weeks: Results From a surveillance, epidemiology, and end Results-Medicare analysis. Cancer. 2009;115(5):988–996.
   PubMed Web of Science ®Google Scholar
• Kulkarni GS, Urbach DR, Austin PC, et al. Longer wait times increase overall mortality in patients With bladder cancer. J Urol. 2009;182(4):1318–1324.
   PubMed Web of Science ®Google Scholar
• Simunovic M, Rempel E, Thériault M-E, et al. Influence of delays to nonemergent Colon cancer surgery on operative mortality, disease-specific survival and overall survival. Can J Surg J Can Chir. 2009;52:E79–E86.
   PubMed Web of Science ®Google Scholar
• Loeb S, Folkvaljon Y, Robinson D, et al. Immediate versus delayed prostatectomy: Nationwide population-based study. Scand J Urol. 2016;50(4):246–254.
   PubMed Web of Science ®Google Scholar
• Auffenberg GB, Linsell S, Dhir A, Michigan Urological Surgery Improvement Collaborative, et al. Comparison of pathological outcomes for men with low risk prostate cancer from diverse practice settings: Similar results from immediate prostatectomy or initial surveillance with delayed prostatectomy. J Urol. 2016;196(5):1415–1421.
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022; Mar 25:S0302-2838(22)01676-1. Epub ahead of print. PMID: 35346519.
   Google Scholar
• Finelli A, Ismaila N, Bro B, et al. Management of small renal masses: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2017;35(6):668–680.
   PubMed Web of Science ®Google Scholar
• Cheung DC, Finelli A. Active surveillance in small renal masses in the elderly: a literature review. Eur Urol Focus. 2017;3(4-5):340–351.
   PubMedGoogle Scholar
• Martínez CH, Martin P, Chalasani V, et al. How long can patients with renal cell carcinoma wait for surgery without compromising pathological outcomes? Can Urol Assoc J. 2011;5(6):e148–e151.
   PubMedGoogle Scholar
• Kim KH, You D, Jeong IG, et al. The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma. J Cancer Res Clin Oncol. 2012;138(9):1561–1567.
   PubMed Web of Science ®Google Scholar
• Shiff B, Breau RH, Patel P, et al. Impact of time to surgery and surgical delay on oncologic outcomes for renal cell carcinoma. J Urol. 2021;205(1):78–85.
   PubMedGoogle Scholar
• Zeng J, Batai K, Lee B. Nephrectomy delay of more than 10 weeks from diagnosis Is associated with decreased overall survival in pT3 RCC. jkcvhl. 2021;8(2):27–33.
   Google Scholar
• Ginsburg KB, Curtis GL, Patel DN, et al. Association of surgical delay and overall survival in patients with T2 renal masses: Implications for critical clinical decision-making during the COVID-19 pandemic. Urology. 2021;147:50–56.
   PubMed Web of Science ®Google Scholar
• Mano R, Vertosick EA, Hakimi AA, et al. The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm. Urol Oncol Semin Orig Investig. 2016;34(5):239.e1-239–e8.
   Web of Science ®Google Scholar
• Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. 2002;94(3):167–173.
   PubMedGoogle Scholar
• Thorstenson A, Bergman M, Scherman-Plogell A-H, et al. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the national swedish kidney cancer register. Scand J Urol. 2014;48(3):231–238.
   PubMed Web of Science ®Google Scholar
• Thorstenson A, Harmenberg U, Lindblad P, et al. Cancer characteristics and current treatments of patients with renal cell carcinoma in Sweden. Biomed Res Int. 2015;2015:456040–456045.
   PubMed Web of Science ®Google Scholar
• Landberg A, Lindblad P, Harmenberg U, et al. The renal cell cancer database Sweden (RCCBaSe) – a new register-based resource for renal cell carcinoma research. Scand J Urol. 2020;54(3):235–240.
   PubMed Web of Science ®Google Scholar
• Landberg A, Bruce D, Lindblad P, et al. Validation of data quality in the national Swedish kidney cancer register. Scand J Urol. 2021;55(2):142–148.
   PubMed Web of Science ®Google Scholar
• Rosenblad AK, Sundqvist P, Westman B, et al. A psychometric evaluation of the functional assessment of cancer therapy—kidney symptom index (FKSI-19) among renal cell carcinoma patients suggesting an alternative two-factor structure. Qual Life Res. 2021;30(9):2663–2670.
   PubMed Web of Science ®Google Scholar
• Guðmundsson E, Hellborg H, Lundstam S, Swedish Kidney Cancer Quality Register Group, et al. Metastatic potential in renal cell carcinomas ≤7cm: Swedish kidney cancer quality register data. Eur Urol. 2011;60(5):975–982.
   PubMed Web of Science ®Google Scholar
• Thorstenson A, Harmenberg U, Lindblad P, Swedish Kidney Cancer Quality Register Group, et al. Impact of quality indicators on adherence to national and European guidelines for renal cell carcinoma. Scand J Urol. 2016;50(1):2–8.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–667.
   PubMed Web of Science ®Google Scholar
• Brierley J, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours. Eighth edition. Chichester, West Sussex, UK ; Hoboken, NJ: John Wiley & Sons, Inc; 2017.
   Google Scholar
• Srivastava A, Patel HV, Kim S, et al. Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond. Urol Oncol Semin Orig Investig. 2021;39:247–257.
   PubMed Web of Science ®Google Scholar